johnson & johnson - Search News

News

Johnson & Johnson, Q2 Estimates

Johnson & Johnson Beats Earnings Estimates. Financial Chief Says It Can Do Any Deal It Wants.

The drug and medical device maker Johnson & Johnson kicked off the healthcare earnings season with a better-than-anticipated report early Wednesday, as sales and earnings came in above expectations.That’s a good sign for the healthcare sector,

Hosted on MSN · 3h

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong demand for its cancer drug, Darzalex, and strength in its medical device business helped it beat Wall Street expectations.

Investopedia on MSN · 6h

Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit

Johnson & Johnson (JNJ) on Wednesday lifted its full-year projections and reported second quarter results that beat estimates. The medical device and drug maker posted adjusted earnings per share of $2.

Mike Johnson calls for 'transparency' in Epstein case

NBC News on MSN · 6h

Mike Johnson calls for Epstein files and ICE memos gives deportation guidance: Morning Rundown

Donald Trump brushes off his supporters’ interest in the Jeffrey Epstein case, and House Speaker Mike Johnson speaks out.

USA TODAY on MSN · 18h

Mike Johnson calls for 'transparency' in Epstein case, in a break with Trump

The House Speaker said he is "for transparency," in a moves that breaks with Trump's calls to move on from the Epstein case review.

CBS News · 4h

Speaker Mike Johnson calls for transparency over Epstein documents

Speaker of the House Mike Johnson, an ally of President Trump, is another Republican who is now calling for greater transparency and the release of the Jeffrey Epstein documents. Johnson also said there needs to be more of an explanation from Attorney General Pam Bondi regarding her comments on the files as the issue divides the GOP.

1hon MSN

Johnson & Johnson’s stock surges as tariff cost estimate slashed and profit outlook raised

Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the ...

10m

Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Johnson & Johnson leads S&P 500 and Dow

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...

Johnson & Johnson shrugs off tariff impact and forecasts sales boost

In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...

C.J. Gardner-Johnson Apologizes to Eagles for 'Won't See a Ring' Comments After Trade

C.J. Gardner-Johnson said he "retracts" the comments he made about the Philadelphia Eagles after he was traded to the Houston ...

Life-Extension Guru Bryan Johnson Says He Has Way More Microplastics in His Semen Than His Blood

Johnson shared yet another personal insight that nobody asked for: His jizz has substantially more microplastics in it than ...

4hon MSN

Democratic state Sen. Nathan Johnson announces run for Texas attorney general

The third-term Democrat from Dallas faces long odds in a state that has only elected Republicans to statewide office for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Johnson & Johnson, Q2 Estimates

Mike Johnson calls for 'transparency' in Epstein case

Related topics